Skip to main content
Clinical Trials/NCT01126359
NCT01126359
Completed
Not Applicable

Lidocaine Analgesia For Removal Of Wound Vacuum Assisted Closure Dressings: A Randomized Double Blinded Controlled Trial

University of Utah1 site in 1 country11 target enrollmentAugust 2008

Overview

Phase
Not Applicable
Intervention
Lidocaine
Conditions
Pain
Sponsor
University of Utah
Enrollment
11
Locations
1
Primary Endpoint
Visual Analog Scale Pain Score
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this prospective study is to compare pain levels and pain medication dose requirements in patients with topical negative pressure (TNP) dressings removed in a standard manner (i.v. or p.o. pain meds) compared to dressings removed with lidocaine analgesia, via injection retrograde up the suction tube into the foam prior to removal. Our null hypothesis is that there will be no difference in overall pain scores or medication requirements when patients receive a saline, control injection and pain medications, compared to when their dressings are changed with a lidocaine injection into the sponge, with pain medications. Our objective is to disprove this null hypothesis with statistical significance.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
March 2010
Last Updated
11 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Kubiak

M.D.

University of Utah

Eligibility Criteria

Inclusion Criteria

  • wounds to which a split-thickness autologous skin graft applied;
  • infected wounds after debridement;
  • open fracture wounds;
  • acute soft-tissue wounds (with exposed tendon, bone, hardware, and/or joint);
  • fasciotomy wounds after compartment syndrome;
  • chronic non-healing wounds;
  • surgical wounds that are difficult to close due to tension; or
  • wounds with external fixation pins or tubes with irritation or drainage.

Exclusion Criteria

  • allergy to lidocaine;
  • allergy to the polyurethane foam or impermeable seal;
  • malignancy associated with the wound;
  • extremity insensate to pain due to any cause (including diabetic neuropathy, or any neurologic disorder therein);
  • pregnancy as diagnosed by urine pregnancy test.

Arms & Interventions

Lidocaine then Placebo-Saline

Intervention: Lidocaine

Lidocaine then Placebo-Saline

Intervention: Placebo-Saline

Placebo-Saline then Lidocaine

Intervention: Lidocaine

Placebo-Saline then Lidocaine

Intervention: Placebo-Saline

Outcomes

Primary Outcomes

Visual Analog Scale Pain Score

Time Frame: 20 minutes

Visial Analog Pain Scores (VAS) range from 0 (no pain) - 10 (worst pain ever). Visial Analog Pain Scores are determined at each pain measurement time point (during/after VAC dressing removal).

Secondary Outcomes

  • Break-through Narcotic Requirement(20 minutes)

Study Sites (1)

Loading locations...

Similar Trials